Cargando…
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
SIMPLE SUMMARY: Prostate cancer treatment has improved over the last 20 years; despite this, approximately 33,000 men died from the disease in the United States in 2020. In view of this, new treatment options are urgently needed for advanced prostate cancer. Eradicating cancer cells by triggering ap...
Autores principales: | Westaby, Daniel, Jimenez-Vacas, Juan M., Padilha, Ana, Varkaris, Andreas, Balk, Steven P., de Bono, Johann S., Sharp, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750516/ https://www.ncbi.nlm.nih.gov/pubmed/35008216 http://dx.doi.org/10.3390/cancers14010051 |
Ejemplares similares
-
MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation
por: Arai, Seiji, et al.
Publicado: (2020) -
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
por: Sheehan, Beshara, et al.
Publicado: (2022) -
Window of Opportunity
Publicado: (1996) -
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis
por: Goc, Anna, et al.
Publicado: (2012) -
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
por: Longo, Joseph, et al.
Publicado: (2020)